Euromena’s strategic investment in Biopharm’s operations in Algeria

Lead party: EuroMena (lead investor/buyer)Coverage: Meridian Capital (investment and transaction tracker; data from Partner Researchers, editorially reviewed). Target: Biopharm Group (public company) · Sector: Healthcare, Pharmaceuticals · Countries of operation: Algeria Transaction type: Investment · Asset class: Private Equity · Strategy: Strategic Minority · Instrument: Equity · Fund: EuroMena Fund II Lead investor/buyer: EuroMena ·…


Lead party: EuroMena (lead investor/buyer)

Coverage: Meridian Capital (investment and transaction tracker; data from Partner Researchers, editorially reviewed).

Target: Biopharm Group (public company) · Sector: Healthcare, Pharmaceuticals · Countries of operation: Algeria

Transaction type: Investment · Asset class: Private Equity · Strategy: Strategic Minority · Instrument: Equity · Fund: EuroMena Fund II

Lead investor/buyer: EuroMena · Investors/buyers: EuroMena

Legal advisers: not identified in the source record.

Source: announced 1 December 2013. Original announcement: euromenafunds.com.